PetIQ Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PetIQ stock.
View analyst ratings for PetIQ or view top-rated stocks.

Wall Street analysts have given PetIQ a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but PetIQ wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

PetIQ is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for PetIQ.

PetIQ, Inc. (NASDAQ:PETQ) issued its quarterly earnings results on Wednesday, May, 5th. The company reported $0.39 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.04 by $0.35. PetIQ had a positive trailing twelve-month return on equity of 4.47% and a negative net margin of 10.13%.
View PetIQ's earnings history.

PetIQ's stock was trading at $22.59 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PETQ shares have increased by 74.5% and is now trading at $39.41.
View which stocks have been most impacted by COVID-19.

PetIQ issued an update on its FY 2021 earnings guidance on Wednesday, May, 12th. The company provided EPS guidance of - for the period. The company issued revenue guidance of $950 million-$950 million, compared to the consensus revenue estimate of $938.13 million.

4 equities research analysts have issued 1-year target prices for PetIQ's shares. Their forecasts range from $45.00 to $175.00. On average, they expect PetIQ's stock price to reach $78.75 in the next year. This suggests a possible upside of 99.8% from the stock's current price.
View analysts' price targets for PetIQ or view top-rated stocks among Wall Street analysts.

10 employees have rated PetIQ CEO Cord Christensen on Glassdoor.com. Cord Christensen has an approval rating of 89% among PetIQ's employees.

Some companies that are related to PetIQ include Nu Skin Enterprises (NUS), (BTCA) (BTCA), Trxade Group (TRXD), Trxade Group (MEDS), Bioasis Technologies (BIOAF), Medizone International (MZEIQ), China Medicine (CHME), ScripsAmerica (SCRCQ) and China BCT Pharmacy Group (CNBI).
View all of PETQ's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), Intel (INTC), CVS Health (CVS), QUALCOMM (QCOM), Editas Medicine (EDIT) and Gilead Sciences (GILD).

(PETQ) raised $86 million in an IPO on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair acted as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

PetIQ trades on the NASDAQ under the ticker symbol "PETQ."

PetIQ's stock is owned by many different institutional and retail investors. Top institutional investors include Waddell & Reed Financial Inc. (9.40%), BlackRock Inc. (7.47%), Geneva Capital Management LLC (4.61%), Riverbridge Partners LLC (3.90%), Ensign Peak Advisors Inc (3.67%) and Russell Investments Group Ltd. (2.85%). Company insiders that own PetIQ stock include John Newland, Mark L First, Michael A Smith, Robert Michael Herrman, Ronald Kennedy, Susan Sholtis and Will Santana.
View institutional ownership trends for PetIQ.

PETQ stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Russell Investments Group Ltd., Riverbridge Partners LLC, Geneva Capital Management LLC, Northern Trust Corp, Gabelli Funds LLC, UBS Group AG, and Boston Partners. Company insiders that have sold PetIQ company stock in the last year include John Newland, Mark L First, Michael A Smith, Robert Michael Herrman, Ronald Kennedy, Susan Sholtis, and Will Santana.
View insider buying and selling activity for PetIQ or view top insider-selling stocks.

PETQ stock was acquired by a variety of institutional investors in the last quarter, including Waddell & Reed Financial Inc., Envestnet Asset Management Inc., RE Advisers Corp, Dimensional Fund Advisors LP, Rothschild & Co. Asset Management US Inc., Geode Capital Management LLC, Peregrine Capital Management LLC, and BlackRock Inc.. Company insiders that have bought PetIQ stock in the last two years include John Newland, and Robert Michael Herrman.
View insider buying and selling activity for PetIQ or or view top insider-buying stocks.

Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PETQ stock can currently be purchased for approximately $39.41.

PetIQ has a market capitalization of $1.14 billion and generates $709.43 million in revenue each year. The company earns $-11,450,000.00 in net income (profit) each year or $1.07 on an earnings per share basis.

PetIQ employs 1,015 workers across the globe.

The official website for PetIQ is www.petiq.com.

PetIQ is headquartered at 923 S. Bridgeway Pl., EAGLE ID, 83616.

PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected]